Nottingham’s hospitals have been awarded £23.6 million from the Government to make world-first medical breakthroughs, as part of a record package of research funding announced today by Health Secretary Jeremy Hunt.

Nottingham already has two Biomedical Research Units (BRUs) in digestive diseases and hearing. BRUs will be replaced by Biomedical Research Centres (BRCs) by April 2017.

Nottingham has been awarded £23.6m of the £816m funding that has gone to NHS and University partnerships across England through the National Institute for Health Research.

Dr Maria Koufali, Deputy Director of Research & Innovation, for Nottingham University Hospitals NHS Trust, said: “We are absolutely delighted to be working with The University of Nottingham, our charity and industry partners, to develop the new Biomedical Research Centre for Nottingham. The new Centre in Nottingham will drive innovation and internationally competitive translational research in therapeutic areas which are highly relevant to the health of our patients and public: gastrointestinal and liver disease, hearing loss and tinnitus, respiratory and musculoskeletal disease and mental health and technology. At the core of our centre will be our world leading expertise in Magnetic Resonance Imaging (MRI). NUH is one of the leading NHS Trusts in developing research which will address important clinical questions and improve outcomes for patients. The new Biomedical Research Centre will further strengthen Nottingham’s position as a leading city for research and innovation.”

Nottingham’s hospitals have a large portfolio of active research programmes for patients and aim to offer every patient the opportunity to participate in research.

For more information about how to get involved in research at your local hospitals, please visit: /research-innovation/  and follow @nuhresearch.

Health Secretary, Jeremy Hunt said: “The UK has so often led the world in health research – from the invention of the smallpox vaccine to the discovery of penicillin and the development of DNA sequencing. Today, we are making sure the UK stays ahead of the game by laying the foundations for a new age of personalised medicine.

“We are supporting the great minds of the NHS to push the frontiers of medical science so that patients in this country continue to benefit from the very latest treatments and the highest standards of care.”

-ENDS-

To view the full press release, please click here.

Latest Opportunities

Study brief: The effects of a recovery gel on endurance cycling performance in the heat

The popularity of endurance sports like cycling and running has grown significantly over the past…

UKRI unveils new £9 million proof-of-concept fund

The UKRI Proof of Concept funding opportunity aims to support and accelerate the development of…

Peer advice on “demand forecasting strategies”

An established Midlands-based health manufacturer is keen to hear from others about their demand forecasting…

Latest News

Digital mental health technologies guidance launched to help manufacturers and safeguard users

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued new guidance to help manufacturers…

Scientific Laboratory Supplies' service arm acquires new company

The dedicated service arm of Scientific Laboratory Supplies Group (SLS), C&M Scientific, has announced the…

Golden Ticket Programme 2025 crowns winner

Melio Bio, a biotech dedicated to the discovery and development of novel inhibitors targeting a…